Clinical Trials Directory

Trials / Completed

CompletedNCT02158325

Capsulorhexis Size and Capsular Outcome

Appropriate Capsulorhexis Size Results in Better Capsular Outcome When Treating Pediatric Cataract: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
2 Years
Healthy volunteers
Not accepted

Summary

Different capsulorhexis size results in different capsular outcome when treating pediatric cataract, and there should be an appropriate capsulorhexis size for the best capsular outcome.

Detailed description

Numerous studies have reported that ideal anterior capsulorhexis size is 4.5-5.0 mm with the capsulorhexis edges covering IOL optic surface because it can inhibit the proliferation and migration of remnant lens epithelial cells (LEC). But there are no reports investigating the relationship between the capsulorhexis size and the capsular outcome after pediatric cataract surgery. Therefore, the aim of the current study is to prospective evaluate the capsular outcomes of three controlled groups receiving different anterior capsulorhexis sizes (3.0-3.9, 4.0-5.0, 5.1-6.0 mm in diameter).

Conditions

Interventions

TypeNameDescription
PROCEDUREanterior capsulorhexis sizesPediatric cataract surgery performed with different anterior capsulorhexis sizes (3.0\~3.9, 4.0\~5.0, 5.1\~6.0 mm in diameter)

Timeline

Start date
2011-03-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2014-06-06
Last updated
2014-06-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02158325. Inclusion in this directory is not an endorsement.